• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

33% of Patients Delay Diagnostic Tests, 78% Fear Blood Drawn, Survey Reveals

by Fred Pennic 10/18/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– A recent survey by Tasso, Inc., a provider of patient-centric blood collection solutions reveals 33% of patients delay or avoid diagnostic blood tests, with the top reasons being inconvenient testing locations and discomfort during blood collection. 

– The survey, Patient Preferences, Perceptions, and the Evolving Challenges of Ensuring Patient Compliance With Diagnostic Healthcare Testing, which polled over 600 adults in the U.S., highlights significant challenges with the current blood collection process and underscores the need for innovative solutions to improve patient experience and compliance.

Inconvenience and Discomfort Hinder Compliance

The survey found that one in three patients delay or avoid diagnostic blood tests due to inconvenience and discomfort. Key findings include:

  • Inconvenient Locations: Patients are unwilling to travel long distances for blood tests, with 69% unwilling to travel more than 10 miles from home.
  • Scheduling Challenges: The most common reason for delaying a prescribed blood test is difficulty scheduling time for a clinic visit.
  • Fear of Needles: 37% of respondents reported a fear of needles, a significant barrier to completing blood tests.
  • Pain and Anxiety: 78% of respondents experience anxiety associated with blood draws, and 87% report some level of pain during venipuncture.

Demand for Patient-Centric Solutions

The survey also revealed a strong demand for solutions that improve the patient blood collection experience:

  • Willingness to Pay: 76% of respondents who experience pain during venipuncture are willing to pay out-of-pocket for less painful options.
  • Interest in Home-Based Testing: 74% of respondents expressed interest in using painless home blood collection technology.
  • Prioritizing Painlessness and Convenience: The top reasons for interest in home-based blood collection were painlessness and convenience.

The Rise of Home Health Testing

While 73% of respondents have purchased a home health testing kit, only 15% have completed a home blood test. This suggests a lack of awareness and familiarity with available home blood collection options.

“This survey validated our assumption that the painful and often inconvenient process of blood collection frequently leads to patient non-compliance and missed care,” said Ben Casavant, PhD, CEO and Co-Founder of Tasso. “Disrupting this model is crucial, as routine blood tests can detect critical health changes early. While patients are more familiar with home testing post-COVID, few have had access to home blood test kits. Offering a painless, at-home option could significantly improve compliance, especially for those with limited access to healthcare facilities.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Kinetik CEO Sufian Chowdhury on Fighting NEMT Fraud & Waste

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |